Ziel
The number of Europeans with paralysis, deformity or orthopaedic impairments that use orthotics will reach 9.6 million by the
year 2020. Orthotics is a speciality involving the application of external devices to the body to support and improve posture,
function and mobility, and manage pain and deformity. The majority of people requiring orthotics are over 50 years old;
demand is expected to increase with the ageing population and the rising prevalence of obesity, cardiovascular disease,
diabetes and stroke, where foot complications and reduced mobility are commonplace.
Approaches to orthotics have not changed in over 50 years. The process takes up to 12 months, and requires technicians,
physiotherapists, orthotists and manufacturers. Often, by the time patient receives their orthotic their condition has
deteriorated or the orthotic no longer fits, resulting in ineffective treatment, repeat visits, poorer clinical outcomes, and higher
risk of surgery.
Families all over Europe are being failed by this service. In order to tackle this challenge, we have developed a streamlined
orthotic 3D scanning, design and printing service. Our orthotic service is the only service in the world capable of delivering
an effective custom orthotic within 1 week of consultation. Our pathway is faster and more cost effective than traditional
methods.
We use a multidisciplinary team, CAD and FEA to optimise design, add strength and flexibility and reduce unwanted
movement, resulting in better patient reported outcomes and quality of life. Our key innovation is the overarching technology
and software that links together the entire service pathway, from consultation to delivery in under a week.
Wissenschaftliches Gebiet
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health sciencesbasic medicineneurologystroke
- medical and health scienceshealth sciencesnutritionobesity
- engineering and technologymedical engineeringwearable medical technology
Programm/Programme
- H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
- H2020-EU.3.1.4. - Active ageing and self-management of health
- H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.1.6. - Health care provision and integrated care
Thema/Themen
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-SMEINST-1-2016-2017
Finanzierungsplan
SME-1 - SME instrument phase 1Koordinator
N1 7GU LONDON
Vereinigtes Königreich
Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).